![]() |
|
|
Vol. 14, Issue 10, 4221-4229, October 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


||
* Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892;
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892;
The Salk Institute, La Jolla, California 92037; and
Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore Maryland 21224
Submitted February 25, 2003;
Revised May 27, 2003;
Accepted May 27, 2003
Monitoring Editor: Pamela Silver
We report a novel nucleolar interaction between the AAA ATPase p97/VCP and the Werner protein (WRNp), a member of the RecQ helicase family. p97/VCP mediates several important cellular functions in eucaryotic cells, including membrane fusion of the endoplasmic reticulum and Golgi and ubiquitin-dependent protein degradation. Mutations in the WRN gene cause Werner syndrome, a genetic disorder characterized by premature onset of aging symptoms, a higher incidence of cancer, and a high susceptibility to DNA damage caused by topoisomerase inhibitors. We observed that both WRNp and valosin-containing protein (VCP) were present in the nucleoplasm and in nucleolar foci in mammalian cells and that WRNp and p97/VCP physically interacted in the nucleoli. Importantly, the nucleolar WRNp/VCP complex was dissociated by treatment with camptothecin, an inhibitor of topoisomerase I, whereas other WRNp-associated protein complexes, such as WRNp/Ku 80, were not dissociated by this drug. Because WRN syndrome cells are sensitive to topoisomerase inhibitors, these observations suggest that the VCP/WRNp interaction plays an important role in WRN biology. We propose a novel role for VCP in the DNA damage response pathway through modulation of WRNp availability.
Abbreviations used: AAA, ATPases associated with diverse cellular activities; CPT, camptothecin; DAPI, 4',6-diamidino-2-phenylindole, dihydrochloride; ER, endoplasmic reticulum; GFP, green fluorescent protein; IP, immunoprecipitate; VCP, valosin-containing protein; WRNp, Werner helicase protein; WS, Werner Syndrome.
|| Corresponding author. E-mail address: indigfr{at}grc.nia.nih.gov.
This article has been cited by other articles:
![]() |
M. A. Gitcho, J. Strider, D. Carter, L. Taylor-Reinwald, M. S. Forman, A. M. Goate, and N. J. Cairns VCP Mutations Causing Frontotemporal Lobar Degeneration Disrupt Localization of TDP-43 and Induce Cell Death J. Biol. Chem., May 1, 2009; 284(18): 12384 - 12398. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mouysset, A. Deichsel, S. Moser, C. Hoege, A. A. Hyman, A. Gartner, and T. Hoppe Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for efficient DNA replication PNAS, September 2, 2008; 105(35): 12879 - 12884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Caruso, S. Jenna, M. Bouchecareilh, D. L. Baillie, D. Boismenu, D. Halawani, M. Latterich, and E. Chevet GTPase-Mediated Regulation of the Unfolded Protein Response in Caenorhabditis elegans Is Dependent on the AAA+ ATPase CDC-48 Mol. Cell. Biol., July 1, 2008; 28(13): 4261 - 4274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Biragyn, R. Schiavo, P. Olkhanud, K. Sumitomo, A. King, M. McCain, F. E. Indig, G. Almanzar, and D. Baatar Tumor-Associated Embryonic Antigen-Expressing Vaccines that Target CCR6 Elicit Potent CD8+ T Cell-Mediated Protective and Therapeutic Antitumor Immunity J. Immunol., July 15, 2007; 179(2): 1381 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Z. Imam, F. E. Indig, W.-H. Cheng, S. P. Saxena, T. Stevnsner, D. Kufe, and V. A. Bohr Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase Nucleic Acids Res., July 11, 2007; (2007) gkm386v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Mimnaugh, W. Xu, M. Vos, X. Yuan, and L. Neckers Endoplasmic Reticulum Vacuolization and Valosin-Containing Protein Relocalization Result from Simultaneous Hsp90 Inhibition by Geldanamycin and Proteasome Inhibition by Velcade Mol. Cancer Res., September 1, 2006; 4(9): 667 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schiavo, D. Baatar, P. Olkhanud, F. E. Indig, N. Restifo, D. Taub, and A. Biragyn Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses Blood, June 15, 2006; 107(12): 4597 - 4605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Klein, M. T. Barati, R. Wu, D. Gozal, L. R. Sachleben Jr., H. Kausar, J. O. Trent, E. Gozal, and M. J. Rane Akt-mediated Valosin-containing Protein 97 Phosphorylation Regulates Its Association with Ubiquitinated Proteins J. Biol. Chem., September 9, 2005; 280(36): 31870 - 31881. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Livingstone, H. Ruan, J. Weiner, K. R. Clauser, P. Strack, S. Jin, A. Williams, H. Greulich, J. Gardner, M. Venere, et al. Valosin-Containing Protein Phosphorylation at Ser784 in Response to DNA Damage Cancer Res., September 1, 2005; 65(17): 7533 - 7540. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Rancour, S. Park, S. D. Knight, and S. Y. Bednarek Plant UBX Domain-containing Protein 1, PUX1, Regulates the Oligomeric Structure and Activity of Arabidopsis CDC48 J. Biol. Chem., December 24, 2004; 279(52): 54264 - 54274. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ahn, J. A. Harrigan, F. E. Indig, D. M. Wilson III, and V. A. Bohr Regulation of WRN Helicase Activity in Human Base Excision Repair J. Biol. Chem., December 17, 2004; 279(51): 53465 - 53474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagahama, Y. Hara, A. Seki, T. Yamazoe, Y. Kawate, T. Shinohara, K. Hatsuzawa, K. Tani, and M. Tagaya NVL2 Is a Nucleolar AAA-ATPase that Interacts with Ribosomal Protein L5 through Its Nucleolar Localization Sequence Mol. Biol. Cell, December 1, 2004; 15(12): 5712 - 5723. [Abstract] [Full Text] [PDF] |
||||